Evidence from genetic analyses of human early liver lesions, primary and metastatic liver tumors, tumor-derived cell lines, and from different rodent models, unequivocally demonstrated that MYC deregulation is a critical alteration in the initiation and progression of HCC. The gene discussed is MYC; the disease is neoplasm.